Send to a Friend Font Size: Increase Decrease

ATR and MIST Related Headlines

Dec 17, 2025 05:00PM Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
Dec 17, 2025 05:00PM Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

ATR and MIST Related Press Releases

Dec 17, 2025 05:00PM Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

ATR and MIST Related SEC Filings